Publication date: 12 July 2017
Source:Cell Host & Microbe, Volume 22, Issue 1
Author(s): Un Yung Choi, Angela Park, Jae U. Jung
KSHV is the etiologic agent of PEL—an aggressive lymphoma. Interestingly, EBV concurrently exists in nearly 70% of PEL cases. In this issue of Cell Host & Microbe, McHugh et al. (2017) develop humanized mouse models for EBV/KSHV co-infection and identify their complementary effect on in vivo tumor formation.
Teaser
KSHV is the etiologic agent of PEL—an aggressive lymphoma. Interestingly, EBV concurrently exists in nearly 70% of PEL cases. In this issue of Cell Host & Microbe, McHugh et al. develop humanized mouse models for EBV/KSHV co-infection and identify their complementary effect on in vivo tumor formation.http://ift.tt/2ug0mcM
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου